SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy
may be effective treatment for prostate cancer. It is not yet known which regimen of hormone
therapy is most effective for stage IV prostate cancer.
PURPOSE: This randomized phase III trial is studying two different regimens of hormone
therapy and comparing how well they work in treating men with stage IV prostate cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
Cancer and Leukemia Group B Eastern Cooperative Oncology Group European Organisation for Research and Treatment of Cancer - EORTC National Cancer Institute (NCI) NCIC Clinical Trials Group